Exabis Library
Welcome to the e-CCO Library!
P271: Epidemiological characteristics and factors associated with ulcerative proctitis progression
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P271: Evolving Targets in Ulcerative colitis: Defining Disease Clearance in the VARSITY Study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P271: Fecal calprotectin at diagnosis is associated with oral steroid use first year of Inflammatory Bowel Disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P271: Predictive factors of a clinical severe course of Crohn’s disease: A monocentric study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P271: Role of magnetic resonance in imaging of mesentery in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P271: Variability in histologic activity of paired same-segment biopsies in Crohn's disease dictates multiple biopsies needed to accurately evaluate histological status
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P272 Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P272: Azathioprine drug monitoring and faecal calprotectin levels in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P272: Developing a novel medication adherence index to determine reasons for nonadherence in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P272: Faecal calprotectin and magnetic resonance imaging are highly accurate to detect endoscopic postoperative recurrence in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P272: Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in Korea
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P272: Psychological burden in newly diagnosed IBD patients: Differences between Crohn's Disease and Ulcerative Colitis in early IBD
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P272: Reduced delay in diagnosis of Crohn's disease in patients presenting with perianal disease: results of a retrospective cohort study at a non-academic, IBD-expert centre in the Netherlands
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P272: Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohort
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P273 Point-of-care bowel ultrasound for detecting ileocolonic inflammation in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P273: Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P273: Inflammatory Bowel Disease and COVID-19 vaccine
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P273: Investigations of the characteristics and efficacy of anti-TNFα agents for optimising treatment in paediatric patients with new-onset Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P273: Prediction of treatment response in Crohn's disease patients using contrast enhanced ultrasound: a pilot study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P273: Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM